The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Routine Testing of Neonatal Hematuria Market Research Report 2025
Synopsis
The global Routine Testing of Neonatal Hematuria market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Routine Testing of Neonatal Hematuria is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Routine Testing of Neonatal Hematuria is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Routine Testing of Neonatal Hematuria in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Routine Testing of Neonatal Hematuria include PerkinElmer, Bio-Rad Laboratories, Trivitron Healthcare Private Limited, BioMedomics, Inc., Luminex Corporation, MP BIOMEDICALS, Synergy Medical Systems LLP, Agilent Technologies, Inc and Thermo Fisher Scientific, Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Routine Testing of Neonatal Hematuria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Routine Testing of Neonatal Hematuria.
Report Scope
The Routine Testing of Neonatal Hematuria market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Routine Testing of Neonatal Hematuria market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Routine Testing of Neonatal Hematuria companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PerkinElmer
Bio-Rad Laboratories
Trivitron Healthcare Private Limited
BioMedomics, Inc.
Luminex Corporation
MP BIOMEDICALS
Synergy Medical Systems LLP
Agilent Technologies, Inc
Thermo Fisher Scientific, Inc
Zivak Technologies
Covidien Plc
AB Sciex LLC
Waters Corp.
Masimo Corp.
Natus Medical Inc.
Segment by Type
Blood Test
Urine Test
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Routine Testing of Neonatal Hematuria companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Routine Testing of Neonatal Hematuria market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Routine Testing of Neonatal Hematuria is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Routine Testing of Neonatal Hematuria is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Routine Testing of Neonatal Hematuria in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Routine Testing of Neonatal Hematuria include PerkinElmer, Bio-Rad Laboratories, Trivitron Healthcare Private Limited, BioMedomics, Inc., Luminex Corporation, MP BIOMEDICALS, Synergy Medical Systems LLP, Agilent Technologies, Inc and Thermo Fisher Scientific, Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Routine Testing of Neonatal Hematuria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Routine Testing of Neonatal Hematuria.
Report Scope
The Routine Testing of Neonatal Hematuria market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Routine Testing of Neonatal Hematuria market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Routine Testing of Neonatal Hematuria companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PerkinElmer
Bio-Rad Laboratories
Trivitron Healthcare Private Limited
BioMedomics, Inc.
Luminex Corporation
MP BIOMEDICALS
Synergy Medical Systems LLP
Agilent Technologies, Inc
Thermo Fisher Scientific, Inc
Zivak Technologies
Covidien Plc
AB Sciex LLC
Waters Corp.
Masimo Corp.
Natus Medical Inc.
Segment by Type
Blood Test
Urine Test
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Routine Testing of Neonatal Hematuria companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Routine Testing of Neonatal Hematuria Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Test
1.2.3 Urine Test
1.3 Market by Application
1.3.1 Global Routine Testing of Neonatal Hematuria Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Routine Testing of Neonatal Hematuria Market Perspective (2019-2030)
2.2 Routine Testing of Neonatal Hematuria Growth Trends by Region
2.2.1 Global Routine Testing of Neonatal Hematuria Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Routine Testing of Neonatal Hematuria Historic Market Size by Region (2019-2024)
2.2.3 Routine Testing of Neonatal Hematuria Forecasted Market Size by Region (2025-2030)
2.3 Routine Testing of Neonatal Hematuria Market Dynamics
2.3.1 Routine Testing of Neonatal Hematuria Industry Trends
2.3.2 Routine Testing of Neonatal Hematuria Market Drivers
2.3.3 Routine Testing of Neonatal Hematuria Market Challenges
2.3.4 Routine Testing of Neonatal Hematuria Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Routine Testing of Neonatal Hematuria Players by Revenue
3.1.1 Global Top Routine Testing of Neonatal Hematuria Players by Revenue (2019-2024)
3.1.2 Global Routine Testing of Neonatal Hematuria Revenue Market Share by Players (2019-2024)
3.2 Global Routine Testing of Neonatal Hematuria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Routine Testing of Neonatal Hematuria Revenue
3.4 Global Routine Testing of Neonatal Hematuria Market Concentration Ratio
3.4.1 Global Routine Testing of Neonatal Hematuria Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Routine Testing of Neonatal Hematuria Revenue in 2023
3.5 Routine Testing of Neonatal Hematuria Key Players Head office and Area Served
3.6 Key Players Routine Testing of Neonatal Hematuria Product Solution and Service
3.7 Date of Enter into Routine Testing of Neonatal Hematuria Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Routine Testing of Neonatal Hematuria Breakdown Data by Type
4.1 Global Routine Testing of Neonatal Hematuria Historic Market Size by Type (2019-2024)
4.2 Global Routine Testing of Neonatal Hematuria Forecasted Market Size by Type (2025-2030)
5 Routine Testing of Neonatal Hematuria Breakdown Data by Application
5.1 Global Routine Testing of Neonatal Hematuria Historic Market Size by Application (2019-2024)
5.2 Global Routine Testing of Neonatal Hematuria Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Routine Testing of Neonatal Hematuria Market Size (2019-2030)
6.2 North America Routine Testing of Neonatal Hematuria Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024)
6.4 North America Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Routine Testing of Neonatal Hematuria Market Size (2019-2030)
7.2 Europe Routine Testing of Neonatal Hematuria Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024)
7.4 Europe Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Routine Testing of Neonatal Hematuria Market Size (2019-2030)
8.2 Asia-Pacific Routine Testing of Neonatal Hematuria Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Routine Testing of Neonatal Hematuria Market Size by Region (2019-2024)
8.4 Asia-Pacific Routine Testing of Neonatal Hematuria Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Routine Testing of Neonatal Hematuria Market Size (2019-2030)
9.2 Latin America Routine Testing of Neonatal Hematuria Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024)
9.4 Latin America Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Routine Testing of Neonatal Hematuria Market Size (2019-2030)
10.2 Middle East & Africa Routine Testing of Neonatal Hematuria Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024)
10.4 Middle East & Africa Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Detail
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer Routine Testing of Neonatal Hematuria Introduction
11.1.4 PerkinElmer Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.1.5 PerkinElmer Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Routine Testing of Neonatal Hematuria Introduction
11.2.4 Bio-Rad Laboratories Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Trivitron Healthcare Private Limited
11.3.1 Trivitron Healthcare Private Limited Company Detail
11.3.2 Trivitron Healthcare Private Limited Business Overview
11.3.3 Trivitron Healthcare Private Limited Routine Testing of Neonatal Hematuria Introduction
11.3.4 Trivitron Healthcare Private Limited Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.3.5 Trivitron Healthcare Private Limited Recent Development
11.4 BioMedomics, Inc.
11.4.1 BioMedomics, Inc. Company Detail
11.4.2 BioMedomics, Inc. Business Overview
11.4.3 BioMedomics, Inc. Routine Testing of Neonatal Hematuria Introduction
11.4.4 BioMedomics, Inc. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.4.5 BioMedomics, Inc. Recent Development
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Detail
11.5.2 Luminex Corporation Business Overview
11.5.3 Luminex Corporation Routine Testing of Neonatal Hematuria Introduction
11.5.4 Luminex Corporation Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.5.5 Luminex Corporation Recent Development
11.6 MP BIOMEDICALS
11.6.1 MP BIOMEDICALS Company Detail
11.6.2 MP BIOMEDICALS Business Overview
11.6.3 MP BIOMEDICALS Routine Testing of Neonatal Hematuria Introduction
11.6.4 MP BIOMEDICALS Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.6.5 MP BIOMEDICALS Recent Development
11.7 Synergy Medical Systems LLP
11.7.1 Synergy Medical Systems LLP Company Detail
11.7.2 Synergy Medical Systems LLP Business Overview
11.7.3 Synergy Medical Systems LLP Routine Testing of Neonatal Hematuria Introduction
11.7.4 Synergy Medical Systems LLP Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.7.5 Synergy Medical Systems LLP Recent Development
11.8 Agilent Technologies, Inc
11.8.1 Agilent Technologies, Inc Company Detail
11.8.2 Agilent Technologies, Inc Business Overview
11.8.3 Agilent Technologies, Inc Routine Testing of Neonatal Hematuria Introduction
11.8.4 Agilent Technologies, Inc Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.8.5 Agilent Technologies, Inc Recent Development
11.9 Thermo Fisher Scientific, Inc
11.9.1 Thermo Fisher Scientific, Inc Company Detail
11.9.2 Thermo Fisher Scientific, Inc Business Overview
11.9.3 Thermo Fisher Scientific, Inc Routine Testing of Neonatal Hematuria Introduction
11.9.4 Thermo Fisher Scientific, Inc Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.9.5 Thermo Fisher Scientific, Inc Recent Development
11.10 Zivak Technologies
11.10.1 Zivak Technologies Company Detail
11.10.2 Zivak Technologies Business Overview
11.10.3 Zivak Technologies Routine Testing of Neonatal Hematuria Introduction
11.10.4 Zivak Technologies Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.10.5 Zivak Technologies Recent Development
11.11 Covidien Plc
11.11.1 Covidien Plc Company Detail
11.11.2 Covidien Plc Business Overview
11.11.3 Covidien Plc Routine Testing of Neonatal Hematuria Introduction
11.11.4 Covidien Plc Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.11.5 Covidien Plc Recent Development
11.12 AB Sciex LLC
11.12.1 AB Sciex LLC Company Detail
11.12.2 AB Sciex LLC Business Overview
11.12.3 AB Sciex LLC Routine Testing of Neonatal Hematuria Introduction
11.12.4 AB Sciex LLC Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.12.5 AB Sciex LLC Recent Development
11.13 Waters Corp.
11.13.1 Waters Corp. Company Detail
11.13.2 Waters Corp. Business Overview
11.13.3 Waters Corp. Routine Testing of Neonatal Hematuria Introduction
11.13.4 Waters Corp. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.13.5 Waters Corp. Recent Development
11.14 Masimo Corp.
11.14.1 Masimo Corp. Company Detail
11.14.2 Masimo Corp. Business Overview
11.14.3 Masimo Corp. Routine Testing of Neonatal Hematuria Introduction
11.14.4 Masimo Corp. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.14.5 Masimo Corp. Recent Development
11.15 Natus Medical Inc.
11.15.1 Natus Medical Inc. Company Detail
11.15.2 Natus Medical Inc. Business Overview
11.15.3 Natus Medical Inc. Routine Testing of Neonatal Hematuria Introduction
11.15.4 Natus Medical Inc. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024)
11.15.5 Natus Medical Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Routine Testing of Neonatal Hematuria Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood Test
Table 3. Key Players of Urine Test
Table 4. Global Routine Testing of Neonatal Hematuria Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Routine Testing of Neonatal Hematuria Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Routine Testing of Neonatal Hematuria Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Routine Testing of Neonatal Hematuria Market Share by Region (2019-2024)
Table 8. Global Routine Testing of Neonatal Hematuria Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Routine Testing of Neonatal Hematuria Market Share by Region (2025-2030)
Table 10. Routine Testing of Neonatal Hematuria Market Trends
Table 11. Routine Testing of Neonatal Hematuria Market Drivers
Table 12. Routine Testing of Neonatal Hematuria Market Challenges
Table 13. Routine Testing of Neonatal Hematuria Market Restraints
Table 14. Global Routine Testing of Neonatal Hematuria Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Routine Testing of Neonatal Hematuria Market Share by Players (2019-2024)
Table 16. Global Top Routine Testing of Neonatal Hematuria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Routine Testing of Neonatal Hematuria as of 2023)
Table 17. Ranking of Global Top Routine Testing of Neonatal Hematuria Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Routine Testing of Neonatal Hematuria Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Routine Testing of Neonatal Hematuria Product Solution and Service
Table 21. Date of Enter into Routine Testing of Neonatal Hematuria Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Routine Testing of Neonatal Hematuria Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Routine Testing of Neonatal Hematuria Revenue Market Share by Type (2019-2024)
Table 25. Global Routine Testing of Neonatal Hematuria Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Routine Testing of Neonatal Hematuria Revenue Market Share by Type (2025-2030)
Table 27. Global Routine Testing of Neonatal Hematuria Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Routine Testing of Neonatal Hematuria Revenue Market Share by Application (2019-2024)
Table 29. Global Routine Testing of Neonatal Hematuria Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Routine Testing of Neonatal Hematuria Revenue Market Share by Application (2025-2030)
Table 31. North America Routine Testing of Neonatal Hematuria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Routine Testing of Neonatal Hematuria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Routine Testing of Neonatal Hematuria Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Routine Testing of Neonatal Hematuria Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Routine Testing of Neonatal Hematuria Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Routine Testing of Neonatal Hematuria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Routine Testing of Neonatal Hematuria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Routine Testing of Neonatal Hematuria Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Routine Testing of Neonatal Hematuria Market Size by Country (2025-2030) & (US$ Million)
Table 46. PerkinElmer Company Detail
Table 47. PerkinElmer Business Overview
Table 48. PerkinElmer Routine Testing of Neonatal Hematuria Product
Table 49. PerkinElmer Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 50. PerkinElmer Recent Development
Table 51. Bio-Rad Laboratories Company Detail
Table 52. Bio-Rad Laboratories Business Overview
Table 53. Bio-Rad Laboratories Routine Testing of Neonatal Hematuria Product
Table 54. Bio-Rad Laboratories Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 55. Bio-Rad Laboratories Recent Development
Table 56. Trivitron Healthcare Private Limited Company Detail
Table 57. Trivitron Healthcare Private Limited Business Overview
Table 58. Trivitron Healthcare Private Limited Routine Testing of Neonatal Hematuria Product
Table 59. Trivitron Healthcare Private Limited Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 60. Trivitron Healthcare Private Limited Recent Development
Table 61. BioMedomics, Inc. Company Detail
Table 62. BioMedomics, Inc. Business Overview
Table 63. BioMedomics, Inc. Routine Testing of Neonatal Hematuria Product
Table 64. BioMedomics, Inc. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 65. BioMedomics, Inc. Recent Development
Table 66. Luminex Corporation Company Detail
Table 67. Luminex Corporation Business Overview
Table 68. Luminex Corporation Routine Testing of Neonatal Hematuria Product
Table 69. Luminex Corporation Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 70. Luminex Corporation Recent Development
Table 71. MP BIOMEDICALS Company Detail
Table 72. MP BIOMEDICALS Business Overview
Table 73. MP BIOMEDICALS Routine Testing of Neonatal Hematuria Product
Table 74. MP BIOMEDICALS Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 75. MP BIOMEDICALS Recent Development
Table 76. Synergy Medical Systems LLP Company Detail
Table 77. Synergy Medical Systems LLP Business Overview
Table 78. Synergy Medical Systems LLP Routine Testing of Neonatal Hematuria Product
Table 79. Synergy Medical Systems LLP Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 80. Synergy Medical Systems LLP Recent Development
Table 81. Agilent Technologies, Inc Company Detail
Table 82. Agilent Technologies, Inc Business Overview
Table 83. Agilent Technologies, Inc Routine Testing of Neonatal Hematuria Product
Table 84. Agilent Technologies, Inc Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 85. Agilent Technologies, Inc Recent Development
Table 86. Thermo Fisher Scientific, Inc Company Detail
Table 87. Thermo Fisher Scientific, Inc Business Overview
Table 88. Thermo Fisher Scientific, Inc Routine Testing of Neonatal Hematuria Product
Table 89. Thermo Fisher Scientific, Inc Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 90. Thermo Fisher Scientific, Inc Recent Development
Table 91. Zivak Technologies Company Detail
Table 92. Zivak Technologies Business Overview
Table 93. Zivak Technologies Routine Testing of Neonatal Hematuria Product
Table 94. Zivak Technologies Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 95. Zivak Technologies Recent Development
Table 96. Covidien Plc Company Detail
Table 97. Covidien Plc Business Overview
Table 98. Covidien Plc Routine Testing of Neonatal Hematuria Product
Table 99. Covidien Plc Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 100. Covidien Plc Recent Development
Table 101. AB Sciex LLC Company Detail
Table 102. AB Sciex LLC Business Overview
Table 103. AB Sciex LLC Routine Testing of Neonatal Hematuria Product
Table 104. AB Sciex LLC Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 105. AB Sciex LLC Recent Development
Table 106. Waters Corp. Company Detail
Table 107. Waters Corp. Business Overview
Table 108. Waters Corp. Routine Testing of Neonatal Hematuria Product
Table 109. Waters Corp. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 110. Waters Corp. Recent Development
Table 111. Masimo Corp. Company Detail
Table 112. Masimo Corp. Business Overview
Table 113. Masimo Corp. Routine Testing of Neonatal Hematuria Product
Table 114. Masimo Corp. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 115. Masimo Corp. Recent Development
Table 116. Natus Medical Inc. Company Detail
Table 117. Natus Medical Inc. Business Overview
Table 118. Natus Medical Inc. Routine Testing of Neonatal Hematuria Product
Table 119. Natus Medical Inc. Revenue in Routine Testing of Neonatal Hematuria Business (2019-2024) & (US$ Million)
Table 120. Natus Medical Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Routine Testing of Neonatal Hematuria Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Routine Testing of Neonatal Hematuria Market Share by Type: 2023 VS 2030
Figure 3. Blood Test Features
Figure 4. Urine Test Features
Figure 5. Global Routine Testing of Neonatal Hematuria Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Routine Testing of Neonatal Hematuria Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Routine Testing of Neonatal Hematuria Report Years Considered
Figure 11. Global Routine Testing of Neonatal Hematuria Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Routine Testing of Neonatal Hematuria Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Routine Testing of Neonatal Hematuria Market Share by Region: 2023 VS 2030
Figure 14. Global Routine Testing of Neonatal Hematuria Market Share by Players in 2023
Figure 15. Global Top Routine Testing of Neonatal Hematuria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Routine Testing of Neonatal Hematuria as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Routine Testing of Neonatal Hematuria Revenue in 2023
Figure 17. North America Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Routine Testing of Neonatal Hematuria Market Share by Country (2019-2030)
Figure 19. United States Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Routine Testing of Neonatal Hematuria Market Share by Country (2019-2030)
Figure 23. Germany Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Routine Testing of Neonatal Hematuria Market Share by Region (2019-2030)
Figure 31. China Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Routine Testing of Neonatal Hematuria Market Share by Country (2019-2030)
Figure 39. Mexico Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Routine Testing of Neonatal Hematuria Market Share by Country (2019-2030)
Figure 43. Turkey Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Routine Testing of Neonatal Hematuria Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. PerkinElmer Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 46. Bio-Rad Laboratories Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 47. Trivitron Healthcare Private Limited Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 48. BioMedomics, Inc. Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 49. Luminex Corporation Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 50. MP BIOMEDICALS Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 51. Synergy Medical Systems LLP Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 52. Agilent Technologies, Inc Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 53. Thermo Fisher Scientific, Inc Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 54. Zivak Technologies Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 55. Covidien Plc Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 56. AB Sciex LLC Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 57. Waters Corp. Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 58. Masimo Corp. Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 59. Natus Medical Inc. Revenue Growth Rate in Routine Testing of Neonatal Hematuria Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
